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Abstract
Background: Parameters predicting the evolution of leptospirosis would be useful for clinicians, as well as to better
understand severe leptospirosis, but are scarce and rarely validated. Because severe leptospirosis includes septic shock,
similarities with predictors evidenced for sepsis and septic shock were studied in a hamster model.
Methodology/Principal Findings: Using an LD50 model of leptospirosis in hamsters, we first determined that 3 days post-
infection was a time-point that allowed studying the regulation of immune gene expression and represented the onset of
the clinical signs of the disease. In the absence of tools to assess serum concentrations of immune effectors in hamsters, we
determined mRNA levels of various immune genes, especially cytokines, together with leptospiraemia at this particular
time-point. We found differential expression of both pro- and anti-inflammatory mediators, with significantly higher
expression levels of tumor necrosis factor a, interleukin 1a, cyclo-oxygenase 2 and interleukin 10 genes in nonsurvivors
compared to survivors. Higher leptospiraemia was also observed in nonsurvivors. Lastly, we demonstrated the relevance of
these results by comparing their respective expression levels using a LD100 model or an isogenic high-passage nonvirulent
variant.
Conclusions/Significance: Up-regulated gene expression of both pro- and anti-inflammatory immune effectors in hamsters
with fatal outcome in an LD50 model of leptospirosis, together with a higher Leptospira burden, suggest that these gene
expression levels could be predictors of adverse outcome in leptospirosis.
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Introduction
Leptospirosis is the most widespread zoonosis occurring
worldwide with possible fatal outcomes [1]. Though most often
an endemic disease, epidemics have been associated with
particular meteorological events [2–4] or clusters of cases related
to occupations or leisure activities [5–8]. It is notably highly
prevalent in tropical areas, but some of the clusters of cases have
been reported in temperate countries [7,8]. Its clinical presenta-
tion is highly variable and is often initially suggestive of influenza,
malaria or dengue fever, making the differential diagnosis more
hazardous in tropical countries, during dengue or influenza
epidemics, or in areas of high malaria incidence [9]. However,
because of a relatively high fatality rate in leptospirosis, increased
medical care must be provided to some of the patients suffering
leptospirosis. Validated prognostic factors to help forecast the
evolution of a leptospirosis are scarce. Yet, they would be valuable
for clinicians to decide whether their patients should only be
treated with antibiotics, kept at the hospital in a standard unit or
directed to an intensive care unit. Few data have been published
addressing this question; furthermore, contrasting observations
were obtained [10,11].
Severe leptospirosis manifestations include acute renal failure,
caused by acute interstitial nephritis and pulmonary haemor-
rhage. Spirochete invasion and toxicity of outer membrane
components cause robust inflammatory host responses [12]
leading to clinical manifestations reflecting a sepsis syndrome.
This latter condition has been characterized as a dysregulation of
the inflammatory response, including a massive release of pro-
inflammatory cytokines that induces multiple organ dysfunctions.
Concomitantly, compensatory mechanisms, mostly regulatory
cytokine-mediated (although having protective effects to prevent
overwhelming inflammation) may become deleterious and have
been associated with an immune paralysis and poor outcome
[13,14].
Cytokines are potent, pleiotropic, non-antigen-binding poly-
peptides secreted by cells of the immune system and are
responsible for cell activation, differentiation and proliferation
after they act on their target cells via specific receptors primarily
through autocrine and paracrine stimulation. Their expression
levels are largely studied in the context of septic shock and severe
sepsis both for their possible prognosis value [13,15–17], as well as
for a better understanding of sepsis physio-pathology [18–20].
Because of high similarities in clinical presentation of septic shock
and severe leptospirosis, we hypothesized that strong similarities in
immune gene expression between severe sepsis and severe
leptospirosis could help predict the evolution of leptospirosis
towards multiple organ failure or recovery.
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systemic inflammation that stimulates the acute phase reaction, in
synergy with interleukin -1 (IL-1) and interleukin-6 (IL-6) [21].
Elevated plasma concentrations of TNFa have been associated
with poor prognosis in sepsis, but also in patients with leptospirosis
[10]. IL-6, one of the most important pro-inflammatory mediators
of the acute phase response to pathogens, has been suggested to be
a downstream mediator of TNFa and IL-1. However, it also
regulates anti-inflammatory effectors by controlling the level of
pro-inflammatory cytokines. Many studies were conducted to
evaluate the value of circulating IL-6 concentrations as indicators
of clinical outcome in patients with severe sepsis, correlating high
levels with fatal outcomes. Interferon-c (IFN-c) is a pluripotent
pro-inflammatory cytokine [22]. Its production was shown as
dependent on IL-12p40 in human blood stimulated by L. interrogans
[23] notably inhibiting Th2 cell activity. Cox-2, one of the two
forms of cyclooxygenase (COX), is highly induced and rapidly
produced in macrophages and endothelial cells in response to
proinflammatory cytokines and may be responsible for the oedema
and vasodilatation associated with inflammation. It is recognized
that inflammatory mediators such as COX-2 but also nitric oxide,
a derived product of inducible nitric-oxide synthase (iNOS), are
responsible for the symptoms of many inflammatory diseases
[24,25]. Increased level of nitric oxide have notably been
evidenced in the sera of patients with severe leptospirosis [26].
Anti-inflammatory effectors play an important role to counter-
regulate the effects of pro-inflammatory cytokines. Interleukin-10
(IL-10) is classically described as an anti-inflammatory cytokine
with pleiotropic effects in immunoregulation and inflammation by
down-regulating the expression of Th1 cytokines [27]. An early
imbalance of IL-10 in sepsis was shown to be associated with death
despite TNFa production. [17]. Transforming Growth Factor b
(TGF-b) is believed to be important in the regulation of the
immune system by regulatory T cells; it notably acts by blocking
the activation of lymphocyte- and monocyte-derived phagocytes
and by controlling iNOS expression [28]. Together with IL-10,
TGFb is considered as contributing to the immunosuppression
observed in septic shock [13,14].
The hamster is considered as the most valuable animal model
for human leptospirosis [29,30]. This animal model is notably used
to maintain virulence of Leptospira strains or isolates. It was also
used in studies aiming at better deciphering the virulence and
pathogenesis mechanisms or the host immune response to
leptospirosis or to vaccine candidates [30–37]. Using this animal
model, our group [38] notably demonstrated in vivo the expression
of Th1 cytokines during acute leptospirosis.
The aim of our study was, using a LD50 model of leptospirosis
in hamsters, to evaluate gene expression levels in individual
animals. Additionally, the Leptospira burden in blood was also
assessed because it was shown to have a prognostic value [39]. The
immune gene expression levels and Leptospira burdens were
compared according to the spontaneous outcome of the
leptospirosis. Differential expression levels were observed that
related to the outcome of the infection.
Methods
Leptospira strain and cultivation
The virulent Leptospira interrogans serovar Icterohaemorrhagiae
strain Verdun, was obtained from the Reference Collection of the
Institut Pasteur in Paris, France. Virulence was maintained by
passages in Syrian golden hamsters (Mesocricetus auratus) and was
regularly tested by lethal injection of 2610
8 leptospires intraper-
itoneally. An avirulent variant corresponding to an isogenic clone
of this strain was derived from the virulent strain by in vitro high-
passage.
Leptospires were cultivated in liquid EMJH (Ellinghausen
McCullough Johnson and Harris) medium at 30uC under aerobic
conditions [40]. The bacterial cell density of the cultures was
assessed in a Petroff-Hausser counting chamber.
Experimental infections
Specific pathogen-free animals which parents were initially
purchased from Charles River Laboratories (Charles River Wiga
GmbH, Sulzfeld, Germany) were bred at the Institut Pasteur of
New Caledonia. All in vivo studies were carried out using five- to
six-week-old outbred golden hamsters handled in individual cages.
During preliminary experiments, we infected hamsters by
intraperitoneal injection of various doses of live virulent Leptospira
ranging from 2610
7 to 2610
8 per hamster. Hamsters were
checked four times a day to evaluate the appearance of clinical
signs, deep unconsciousness or recovery. Deeply unconscious
animals that did not react to a tactile stimulus were considered
dead and euthanized. Additional preliminary experiments includ-
ed the determination of the time course of gene expression by
sampling three individual infected hamsters at 0, 4, 8, 14 hrs then
day 1 (D1), D2, D3, and D4 post-infection to determine the most
relevant time point allowing to evaluate the expression level of as
many relevant genes as possible for future experiments. Each LD50
experimental set was composed of six- to eighteen animals
intraperitoneally infected with 10
8 leptospires of a virulent culture
in EMJH medium, and three or four negative controls injected
with sterile EMJH medium. The study was made up of three
independent experiments. Whole blood (400 ml) was collected on
PAXgene blood RNA tubes (PreAnalytiX, Qiagen, Australia) by
cardiac puncture under non lethal gas anaesthesia [29] on D3 after
infection. Clinical symptoms and/or death were monitored four
times daily for 21 days. Surviving animals at D21 were considered
as spontaneously recovering. Negative controls and surviving
animals were euthanized at D21. In order to evaluate the effect of
the infective dose on the gene expression patterns, we used two
other experimental infection models. We first injected five
hamsters with a LD100 of the same virulent Leptospira, with
2610
8 leptospires injected per hamster using the same intraper-
Author Summary
Leptospirosis is a widespread bacterial infection that is
transmitted by soil or water contaminated by the urine of
infected animals, or directly from these animals. It has
highly diverse clinical presentations, making its differential
diagnosis difficult. Though most cases are minor and self-
resolving, there are also severe forms that include a sepsis
pattern and multiple organ failure, and have possible fatal
outcomes. Predictors of disease evolution and outcome
are scarce, yet they would be very valuable to clinicians as
well as to better decipher disease pathogenesis. In this
study, we used a hamster model of leptospirosis to
evaluate if immune genes were differentially expressed
between individuals and if their expression levels could
help forecast the outcome of the disease. We found that
hamsters that later died from leptospirosis had significant-
ly higher expression levels of both pro- and anti-
inflammatory mediators compared to survivors. These
results suggest that expression levels of these immune
effectors might be helpful predictors of outcome in
leptospirosis and that septic shock contributes to fatal
leptospirosis.
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dose (2610
8 leptospires per hamster) of the high-passage isogenic
Leptospira variant, known not to induce any mortality. Control
animals were similar to the LD50 experiments and were injected
with an equal volume of sterile EMJH. Protocols for animal
experiments were prepared and conducted according to the
guidelines of the Animal Care and Use Committees of the Institut
Pasteur and followed European Recommendation 2007/526/EC
that provides ‘‘guidelines for the accommodation and care of
animals used for experimental and other scientific purposes’’. The
protocol was validated before the start of the experiments by a
scientific committee and an animal care committee of the Institute
Pasteur in New Caledonia.
Total RNA isolation and cDNA synthesis
Total RNA was isolated from whole blood not later than
24 hours post-collection using the PAXgene Blood RNA system
(PreAnalytiX) according to manufacturer’s instructions, then
immediately frozen at 280uC until use. DNase-treated RNAs
were used to synthesize cDNA with the Transcriptor First Strand
cDNA Synthesis Kit using random hexamers as specified by the
manufacturer (Roche Applied Science). To minimize variation in
the reverse transcription reaction, all RNA samples from a single
experimental setup were reverse transcribed simultaneously and in
duplicate.
Primers and standard curves
The sequences of all primers used in this study are listed in
table 1. They were designed with the LightCycler Primer Probe
Design Software 2.0 (Roche Applied Science), selected according
to intron spanning and GC%, and synthesized by Proligo
Singapore Pte Ltd (Biopolis way, Singapore).
External standard curves either for household or effector genes
consisted of serial dilutions of specific purified DNA ranging from
10
7 to 1 copies as described previously [38]. The copy number of
each standard was calculated by standard methods using the
Avogadro constant and the size of the amplified target as described
[41]. Each standard curve was validated using established criteria
(specific melting temperature, size of the PCR product, a mean
error #0.03 and a slope near 23.3).
Real-Time PCR amplification
PCR amplifications and analysis were achieved using a
LightCycler 2.0 instrument (Roche Applied Science) with software
version 4.05. All reactions were performed in duplicates with the
LightCycler FastStart DNA Master SYBR Green I kit (Roche
Applied Science) in a final 20 ml volume with 4 mM MgCl2,
0.5 mM of each primer and 2 mL cDNA or 2 mL DNA standard
dilution. Cycle conditions were optimized for each target, either
immune mediator or b-actin. Amplification conditions consisted of
an initial pre-incubation at 95u for 10 min (polymerase activation)
followed by amplification of the target cDNA for 45 cycles (95uC
for 8 s, 60uC for 5 s and a variable extension time at 72uC).
Extension periods varied for each PCR depending on the
length of the expected amplicon (,1 s/25 bp) as shown in
table 1.
Leptospiraemia was also determined after cDNA amplification
with a PCR specific of a 331 bp sequence of the L. interrogans rrs
(16S) gene [42] using a LightCycler 480 II instrument with
software version 1.5.0. Amplification reactions were performed in
duplicates with the LightCycler 480 SYBR Green I Master kit in a
final 10 mL volume with 0.5 mM of each primer, 1 mL cDNA as
follow: a 10 min enzyme activation at 95uC then 50 amplification
cycles, each made of 8 s at 95uC, 5 s at 62uC and 12 s at 72uC. A
negative control with PCR-grade water instead of cDNA was
included in each run. With either instrument, melting peaks were
automatically plotted by the software and used to assess the
specificity of the amplified product.
Results expression and statistical analysis
Absolute quantification of each target was done using the
comparative cycle threshold (CT) method: the concentration of a
given target mRNA in any unknown sample was calculated by
comparing its CT with the corresponding standard curve. Relative
Table 1. Primers used in this study, amplicon size and elongation time.
Primers Accession number Sequence Amplicon size (bp) Elongation time (sec)
TNF-a forward AF046215 AACGGCATGTCTCTCAA 278 10
TNF-a reverse AGTCGGTCACCTTTCT
IFN-c forward AF034482 GACAACCAGGCCATCC 226 10
IFN-c reverse CAAAACAGCACCGACT
TGF-b forward AF046214 ACGGAGAAGAACTGCT 245 10
TGF-b reverse ACGTAGTACACGATGGG
IL-10 forward AF046210 TGGACAACATACTACTCACTG 308 12
IL-10 reverse GATGTCAAATTCATTCATGGC
IL-1a forward AB028235 AGTTCGTCCTGAATGATTCC 202 10
IL-1a reverse TGGTCTTCACCCTGAGC
IL-6 forward AB028635 AGACAAAGCCAGAGTCATT 252 10
IL-6 reverse TCGGTATGCTAAGGCACAG
COX-2 forward AF345331 CAACTCCCTTGGGTGTGA 173 8
COX-2 reverse TCCTCGTTTCTGATCTGTCT
b-actin forward AF046210 TCTACAACGAGCTGCG 357 12
b-actin reverse CAATTTCCCTCTCGGC
doi:10.1371/journal.pntd.0000582.t001
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number to b-actin mRNA copy number. This ratio was then
normalized using the same ratio calculated in uninfected controls
(used as calibrators). This expression of the results allows directly
providing an n-fold change ratio in gene expression of the
experimental animals compared to their control counterparts. In
this study, b2actin was used as the household reference gene since
former work demonstrated that no significant difference was
observed using either HPRT or b2actin [38].
The outcomes were defined as the spontaneous outcome of the
infection and were either death (‘‘nonsurvivors’’) or spontaneous
recovery (‘‘survivors’’). The results of three independent LD50
experiments were pooled and compared according to the outcome
using Student’s t test and Kruskal-Wallis test on Stata SE/8.0 for
Windows (Stata Corporation, Texas, USA). The overall survival
curve for all LD50 experiments was also plotted with 95%
confidence intervals using Stata SE/8.0.
Results
Preliminary and experimental infections results
Preliminary experiments demonstrated that a dose of 10
8 live
virulent leptospires per hamster injected by the intra-peritoneal
route led to ca. 50% mortality, a dose therefore used for our LD50
experiments. The first signs of illness (prostration and anorexia)
were observed at day 3 post-infection. This dose was confirmed in
further experiments as being a relevant and reproducible model of
LD50 (figure 1A). The relative normalized gene expression levels
at various time points are summarized in figure 1B. After a rapid
and intense rise to its maximum, TNFa expression rapidly
decreased before to slowly and regularly increase again up to
D3. A similar pattern was observed for IL-1 and IL-6 with much a
higher amplitude of regulation. After no significant modulation
during the first 14 hrs post-infection, IL-10 and COX-2 were
expressed at a maximum level around D3 after a steady increase
notably for IL-10. IFNc expression levels were poorly modulated
along this time-course. However its maximum expression level
became relatively stable around D3. Reproducible results were
obtained for all these effectors with RNA extracted from 400 mL
whole blood, except IL-2 and IL-4, because of their low mRNA
copy numbers. Additionally, the peak of IL-12p40 gene expression
was observed very early at 4 hours post-infection. Therefore these
3 latter effectors (IL-2, IL-4 and IL12p40) were not analysed in
further studies.
Taken together, these results led to determine D3 as a relevant
time point for future studies, a consensus when most of the
relevant effectors could be efficiently monitored and the
appearance of the first clinical signs before any mortality occurs.
In the LD100 experiment, all 5 infected hamsters died at D5. As
expected, all hamsters infected with a similarly high dose (2610
8
per hamster) of the high-passage isogenic variant survived until
D21 and were euthanized.
Leptospira burdens and expression levels of some
immune genes are different according to the outcome
In total, 36 infected hamsters were included from our three
independent LD50 infection challenges. Twenty two of them died
at 6.1 (range 4.04–6.92) days post-infection (nonsurvivors),
whereas 14 were considered as spontaneously recovering being
alive at D21 (survivors). Gene expression levels evidenced that the
pro-inflammatory cytokines IL-1a and TNFa but also the enzyme
Cyclooxygenase-2 and the cytokine IL-10 were expressed at
significantly higher levels (p,0.01, see table 2) in nonsurvivors
when compared to survivors (Figure 2A).
Considering the basic criterion that a 2-fold change in transcript
abundance represents differential expression [43,44], the gene
expression levels in survivors were not significantly different from
controls (i.e. relative normalized gene expression levels in the
range 0.5–2, see table 2).
As expected, the live Leptospira burdens, as evaluated by the ratio
of Leptospira 16S rRNA to hamster b-actin, were nil in controls and
were also significantly (p,0.01, see table 2) lower in spontaneously
recovering survivors (figure 2B).
Figure 1. Preliminary experiments results leading to the
selection of day 3 post-infection (as shown by the red lines)
as an appropriate study time point. A. Time course of mortalities in
the LD50 infection model (n=70, green line) and in the animals
sampled for the gene expression studies (n=36, blue line). B. Relative
normalized gene expression levels (see text) time courses (y-axes use
different scales for different gene targets).
doi:10.1371/journal.pntd.0000582.g001
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Leptospira LD50 infection
Contrastingly, the expression of the cytokines IFNc and TGFb
appeared poorly modulated, their expression levels in infected
animals being not significantly different from that in control
animals (ratio not different from 1). Additionally, no difference in
expression levels was observed between survivors and nonsurvivors
after the Leptospira LD50 challenge (table 2 and figure 3). Though
IL-6 is notably induced as a response to the LD50 infectious
challenge (i.e. ratio significantly higher than 1.0), similar levels
(p.0.1, see table 2) were observed in hamsters whatever the
outcome of the LD50 infection. However and interestingly, two
out of our three independent experiments, higher IL-6 expression
levels were observed in nonsurvivors in two out of our 3
independent experiments and a very high expression level in a
few survivors accounted for the similar average expression (see
figure 3 insert).
Comparisons with LD100 and a similarly high dose of an
avirulent variant
Hamsters infected with a high (LD100) dose of virulent Leptospira
displayed a gene expression pattern very similar to the one
observed in nonsurvivors after the LD50 infection challenge. They
displayed a similarly increased gene expression of IL-1a, TNFa
and Cox-2 and a very similar Leptospira burden (figure 2). Their
mean IL10 gene expression level was higher than in nonsurvivors
after the LD50 challenge but this difference was not significant,
due to high inter-individual variability. IFNc and TGFb
expression levels were very poorly modulated, again not
significantly different from uninfected controls (figure 3). Similar
to IL-10, IL-6 gene expression was largely increased compared to
animals infected with a lower dose but a high inter-individual
variability was also noted.
In hamsters infected with a similarly high dose of the high-
passage non-virulent Leptospira variant, the gene expression pattern
was similar to the one displayed by survivors of the LD50
challenge. Surprisingly, a leptospiraemia was still observed at D3
in most of the animals, though no clinical sign was noted and no
mortality occurred.
Discussion
We first developed a LD50 model of leptospirosis in hamsters.
Used together with a non-lethal blood sampling technique, it
allowed the acquisition of individual gene expression patterns
during the course of acute leptospirosis. Using this model, we
demonstrated that the expression of some immune genes in blood,
together with the Leptospira burden in blood of infected animals
could be correlated with the outcome of the infection.
The hamster is recognized as a good animal model for severe
human leptospirosis [29]. Using the virulent Leptospira interrogans
Icterohaemorragiae strain Verdun [45,46], we determined the
dose of 10
8 live leptospires injected via the intra-peritoneal route as
leading to ca. 50% mortality. This challenge technique proved to
be reproducible in 5 to 6-week old Syrian hamsters and was used
for our study. When infected this way, the first clinical signs in
hamsters held in individual cages (anorexia, then prostration and
ruffled fur) were observed from 3 days post-infection on. This 3-
day post-infection time point was also shown, in another
experimental hamster model of leptospirosis, to be the time point
for the first detection of Leptospira mRNA in target organs and a
relevant time point for immune gene expression studies [47]. The
use of a non-lethal sampling technique together with the follow up
of individual hamsters allowed relating the gene expression levels
observed with the individual outcome. We additionally conducted
two experimental infection experiments for comparison purpose,
one using a high dose of the virulent strain (2610
8 live leptospires
via the intra-peritoneal route) leading to 100% mortality and a
similarly high dose of an isogenic avirulent variant causing no
mortality.
During these preliminary experiments, we determined that a
400 mL blood collection under gas anesthesia at this time point
would not be too deleterious to the animals and was sufficient to
allow the extraction of mRNA in adequate quantity and quality
for gene expression studies. Based on our previous knowledge [38]
and with additional preliminary experiments, we determined that
TNFa, IL-1a, IL-6, IL-10, IFNc, TGFb and Cox2 gene
expression levels could successfully be quantified using this
experimental procedure. These targets were chosen for their
relevance in studying our hypothesis of similarities between severe
leptospirosis and septic shock. Only those evidencing a significant
number of mRNA copy numbers at this time point, therefore
allowing accurate determination of the gene expression levels,
were studied.
The Leptospira burden was reported to be of prognostic value in
human leptospirosis [39]. In our study, it was evaluated by q-RT-
PCR targeting the 16S-rRNA allowing to evaluating the burden of
mostly live leptospires, bacterial rRNAs being very short-lived
Table 2. Relative normalized gene expression levels and Leptospira burdens of the hamsters at day 3 post-infections and p-values
according to outcome in the LD50 experiments.
Recovering LD50
(n=14)
Dead LD50
(n=22)
Student’s
tt e s t
Kruskal
Wallis
Dead LD100 (virulent
strain) (n=8)
Avirulent strain
(n=10)
(10
8 leptospires/hamster) p (LD50 infections) (2610
8 leptospires/hamster)
TNFa 1.65 4.51 ,0.001 ,0.001 4.74 1.11
IL1a 1.85 7.04 0.002 ,0.001 6.62 1.20
Cox2 1.31 2.38 0.007 0.005 2.65 1.35
IL10 0.52 3.71 ,0.001 ,0.001 9.36 1.77
TGFb 1.07 1.06 0.975 0.338 1.08 0.83
IFNc 0.97 1.45 0.086 0.067 1.26 0.77
IL6 5.48 4.36 0.666 0.135 2.02 3.29
Lepto 16S rRNA 0.73 8.51 0.002 0.0001 9.07 1.97
doi:10.1371/journal.pntd.0000582.t002
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Leptospira 16S rRNA copy number to host b-actin mRNA copy
number allowed a comparison between individuals. As expected
and observed in humans [39], significantly higher Leptospira
burdens were noticed in nonsurvivors. Interestingly, a leptospir-
aemia was still observed at D3 in animals infected with a high dose
of the avirulent Leptospira variant, suggesting that this high-passage
variant, though not lethal, has retained some degree of
pathogenicity. This also suggests that leptospiraemia might be
strain- and virulence-dependent, possibly jeopardizing its use as a
tool for prognosis, when the virulence of the infecting strain is not
known.
The immune response to an infection is nowadays considered as
precisely modulated rather than simply induced. Cytokines
expression levels are largely studied in the context of septic shock
and severe sepsis both for their possible prognostic value [13,15–
17] and as a way to improve our understanding of host-pathogen
interactions. Actually, sepsis is now recognized as associated with
an exacerbated production of both pro- and anti-inflammatory
cytokines and the prognostic value of some of these is widely
recognized [20].
Using reverse transcription-real-time PCR, the transcripts can
be quantified directly in a biological sample, providing information
about the in vivo immune response mechanisms of the individual.
Studying the immune response is only possible at the transcrip-
tional level in our animal model, due to the lack of tools for
assessing serum conentrations of immune efectors. however, it is
also probably more sensitive to evaluate the fine-tuning of the
immune response because the amount of circulating cytokines only
represents a minor part of the total amount of cytokines produced
[50].
Our results in the LD50 model evidenced differential gene
expression according to the outcome. TNFa, IL-1a, Cox-2 were
expressed at significantly higher levels in nonsurvivors than in
spontaneously recovering hamsters. Using the other two infection
models, the results demonstrated similar gene expression levels in
Figure 2. Mean expression levels of differentially expressed genes (relative normalized expression, see text). Expression levels are
shown at day 3 post-infection in the LD50 Leptospira infection (according to the outcome) and after the injection of a high dose of a virulent or the
high-passage variant (A) and Leptospira burdens (B) in infected hamsters. Error bars indicate 95% confidence intervals.
doi:10.1371/journal.pntd.0000582.g002
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LD50 challenge on one hand, and on the other hand in survivors
after a LD50 and animals infected with a high dose of the avirulent
variant, both actually surviving. These similarities using different
doses and strains confirm the validity of our results.
Our IL-1 RT-PCR targets IL1a, one of the two main active
forms in the IL-1 family. IL-1b is most often considered as the
prototypic IL-1 effector because it is released in the bloodstream,
whereas Il-1a mostly remains cytosolic with an autocrine activity
or is bound to the cell surface. Though IL-1b was more frequently
considered as an indicator of Il-1 activity, IL-1a was shown to
have an action very similar to the action of the more largely
studied IL-1b. Furthermore, it was shown that its gene expression
is quite similarly regulated [51–53]. TNFa and IL-1 are prototypic
pro-inflammatory mediators that have been reported to have a
prognosis value in sepsis [16,54], even if their clinical relevance
was also questioned [55]. Interestingly, TNFa was also reported to
have a similar prognosis value in leptospirosis [10], though these
results were not confirmed in other studies [11]. Cox-2 is a highly
inducible enzyme involved in the early phase of the inflammatory
response. Notably induced by IL-1 and TNFa through the NFkB
pathway, its induction can be considered as an end-result of the
initial pro-inflammatory response. Interestingly, a significant
induction of Cox-2 was observed only in nonsurvivors whatever
the infective dose. This further suggests the probable contribution
of a sepsis-like mechanism in severe leptospirosis. IL-10 is
expressed at higher levels in nonsurvivors compared to the
survivors in the LD50 model. These results are in agreement with
several studies showing an exacerbated production of anti-
inflammatory cytokines resulting in aggravation of a systemic
disease and adverse outcome in febrile patients [14,17]. The
decreased production of Th1 cytokines in many cellular types was
reported as an IL-10-induced adaptative immune response, by
interfering on antigen-presenting cells and T cells, possibly via
inhibition of NFkB nuclear translocation [14,56]. This immuno-
regulatory role of IL-10 was clearly established after an anergy was
observed in stimulated T cells in the presence of IL-10. Moreover,
Il-10 production in innate immune response to a stimulus
promotes the expansion of regulatory T cells, amplifying the
anti-inflammatory effect of IL-10 [13,14,56].
However, the results observed with the other two infection
models suggest a possible effect of the infective dose on IL-10
expression levels, higher levels being noted in animals infected
with a high Leptospira dose (either virulent or not) when compared
to their respective counterparts with the same outcome in the
LD50 model. The IL-10/TNFa ratio has been proposed as a
prognosis indicator in sepsis [17,54] and in leptospirosis [57]. A
high IL-10/TNFa ratio was reported as correlated with poor
outcome in septic patients, contrary to the opposite results
obtained in one limited study reported in leptospirosis [57]. This
ratio was generally regarded as reflecting a persistent secretion of
IL-10 at later time points, when concomitant down-regulation of
TNFa occurs. From our experiments, this ratio, at least at the
transcriptional level, does not appear relevant, both cytokines
being induced in animals with fatal outcome, at least on the basis
of our D3 time-point.
Figure 3. IFNc, TGFb and IL-6 gene expression levels at day 3 post Leptospira infection (relative normalized expression, see text).
Error bars indicate 95% confidence intervals. The insert shows the high variability observed in IL-6 gene expression levels.
doi:10.1371/journal.pntd.0000582.g003
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marker of the severity of infectious (or even non-infectious) stress in
humans and to have a prognosis value in sepsis [20], was not
differentially expressed according to the outcome. However, our
results merely reflect a very high inter-individual variability in IL-6
expression. Contrastingly, IL-6 expression in hamsters infected
with (and dying from) a LD100 of Leptospira actually showed a
highly increased expression, though again with a very high
variability. Similarly, high fluctuations of bioactive IL-6 levels were
reported in serum from septic patients [58]. This high variability
would also be limiting the value of IL-6 as a predictor in
leptospirosis.
In our model, IFNc and TGFb had no prognostic value and
were similarly expressed in infected hamsters whatever the dose or
the outcome. Interestingly, the gene expression of IFNc and
TGFb appeared not being significantly regulated based on the
common 2-fold variation criterion [43,44]. Because IFN-c gene
expression is antigen-presenting cells dependent, we could
hypothesize that high Il-10 levels limited its expression, though it
could have been beneficial for an optimal defense against
infection.
However, some cytokines have been shown not to be regulated
at a transcriptional level and post-transcriptional regulation also
plays a major role in cytokine cascades even after a transcriptional
regulation has occurred. Unfortunately in the hamster, our animal
model, no tool is available to evaluate the serum concentrations of
the effectors studied. On one hand, gene expression techniques
allow a rapid and highly sensitive study of immune gene
transcriptional regulation, notably because the circulating part of
cytokines is considered as being the ‘‘tip of the iceberg’’ [50]. On
the other hand, some immune mediators of the septic shock are
known to be poorly regulated at the transcriptional level and can
therefore not be studied in our model. As an example, High-
mobility group box (HMGB)-1 is primarily known as a nuclear
DNA-binding protein with a transcription regulatory activity, but
can also be excreted by stimulated macrophages, then displaying a
cytokine activity, notably inducing the release of TNFa and IL-6
[59]. It has been proposed as a prototypic late mediator of
inflammation in severe sepsis [60], its delayed and prolonged
release in established sepsis rising an increasing interest as a
prognostic indicator or a therapeutic target in late-phase
inflammation processes. Its usefulness as a prognostic indicator
or as a therapeutic target remains unexplored in leptospirosis.
Though obtained in an animal model with Leptospira strains of
known and relatively low virulence, these encouraging results
prompted us to initiate a clinical study aiming at investigating the
prognostic value of these effectors in patients with confirmed
leptospirosis. Cytokines will similarly be studied at the gene
expression level, but also by measuring their serum concentration
levels, a technique much easier transmissible to health centers.
This study is currently underway.
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